Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 13;8(1):e12293.
doi: 10.1002/trc2.12293. eCollection 2022.

Reduced dementia incidence after varicella zoster vaccination in Wales 2013-2020

Affiliations

Reduced dementia incidence after varicella zoster vaccination in Wales 2013-2020

Christian Schnier et al. Alzheimers Dement (N Y). .

Abstract

Introduction: Chronic infection with herpes viruses is a potential contributing factor to the development of dementia. The introduction of nationwide shingles (varicella zoster) vaccination in Wales might therefore be associated with reduced incident dementia.

Methods: We analyzed the association of shingles vaccination with incident dementia in Wales between 2013 and 2020 using retrospectively collected national health data.

Results: Vaccinated individuals were at reduced risk of dementia (adjusted hazard ratio: 0.72; 95% confidence interval: 0.69 to 0.75). The association was not modified by a reduction in shingles diagnosis and was stronger for vascular dementia than for Alzheimer's disease. Vaccination was also associated with a reduction in several other diseases and all-cause mortality.

Discussion: Our study shows a clear association of shingles vaccination with reduced dementia, consistent with other observational cohort studies. The association may reflect selection bias with people choosing to be vaccinated having a higher healthy life expectancy.

Keywords: Alzheimer's disease; shingles; vaccine; vascular dementia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. CS: received funding from the Benter Foundation (to the University of Edinburgh) for research and visits to AAIC and EAN conferences. JJ: no funding to declare. RL: received funding from the Benter Foundation (to the University of Edinburgh) for research; consulting fees to himself from Life Science Capital and the University of Edinburgh; funding to attend meetings to himself from Prevention Alzheimer International Foundation (International Conference of Chronic Inflammatory Disorders – Alzheimer's Disease), Associazione Autonoma Aderent alla SIN per le Demenze (SINDem; 7th Winter Seminar in Clinical and Experimental Research on Dementia and Neurodegenerative Disorders), Societa Italiana de Neurologia (Sin; 7th Winter Seminar in Clinical and Experimental Research on Dementia and Neurodegenerative Disorders), Deutsche Forschungs Gemeinschaft and the Pesl‐Alzheimer‐Stiftung (2nd International Conference on Cognitive Reserve in Dementia). JH: received funding from the Benter Foundation, BBSRC, MRC, and Wellcome Trust (to the University of Edinburgh) for research and consulting fees (to the University of Edinburgh) from Pneumagen Ltd.

Figures

FIGURE 1
FIGURE 1
Results (adjusted hazard ratio [HR] and 95% confidence interval [CI]) from the multivariable Cox proportional hazard model of the association between exposure to shingles vaccination and dementia. A, Classified by type of dementia (Alzheimer's disease; and vascular dementia). The comparison group (HR = 1.0) was not vaccinated. B, Classified by exposure (S+V−: shingles, not vaccinated; S−V+: no shingles, vaccinated; S+V+: first shingles, then vaccinated; V+S+: first vaccinated, then shingles). The comparison group is no shingles, not vaccinated. Full results of both models are given in the supporting information
FIGURE 2
FIGURE 2
Results (adjusted hazard ratio [HR]; and 95% confidence interval [CI]) from the multivariable Cox proportional hazard models of the association between exposure to shingles vaccination and shingles, all‐cause mortality, stroke, myocardial infarction, hip fracture, and cancer. The comparison group (HR = 1.0) was not vaccinated. MI, myocardial infarction

References

    1. Verreault R, Laurin D, Lindsay J, De Serres G. Past exposure to vaccines and subsequent risk of Alzheimer's disease. CMAJ 2001;165:1495‐8. - PMC - PubMed
    1. Klinger D, Hill BL, Barda N, et al. Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer's Disease and Parkinson's Disease. Vaccines 2021;9:491. 10.3390/vaccines9050491 - DOI - PMC - PubMed
    1. Scherrer JF, Salas J, Wiemken TL, Jacobs C, Morley JE, Hoft DF. Lower risk for dementia following adult tetanus, diphtheria, and pertussis (Tdap) vaccination. Journals Gerontol Ser A 2021;XX:1‐8. 10.1093/gerona/glab115 - DOI - PubMed
    1. Liu JC, Hsu YP, Kao PF, et al. Influenza vaccination reduces dementia risk in chronic kidney disease patients: a population‐based cohort study. Med (United States) 2016;95. 10.1097/MD.0000000000002868 - DOI - PMC - PubMed
    1. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007;7:658‐66. - PubMed

LinkOut - more resources